Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Broadcom
AVGO
|
+$910M |
| 3 |
Amazon
AMZN
|
+$833M |
| 4 |
Tesla
TSLA
|
+$824M |
| 5 |
Workday
WDAY
|
+$753M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$6.93B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$969M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$586M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$476M |
| 5 |
Palo Alto Networks
PANW
|
+$473M |
Sector Composition
| 1 | Technology | 20.46% |
| 2 | Consumer Discretionary | 10.44% |
| 3 | Healthcare | 5.61% |
| 4 | Communication Services | 5.39% |
| 5 | Financials | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4051
ProFrac Holding
ACDC
$695M
| $490K | ﹤0.01% |
57,772
-19,817
| -26% | -$168K |
|
4052
Ducommun
DCO
$1.39B
| $490K | ﹤0.01% |
+9,408
| New | +$490K |
|
|
CRIT
4053
DELISTED
Optica Rare Earths & Critical Materials ETF
CRIT
| $489K | ﹤0.01% |
26,061
+5,428
| +26% | +$102K |
|
4054
Prime Medicine
PRME
$825M
| $489K | ﹤0.01% |
+55,219
| New | +$489K |
|
|
CDMO
4055
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $489K | ﹤0.01% |
75,184
+37,741
| +101% | +$245K |
|
|
NWLI
4056
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $488K | ﹤0.01% |
+1,011
| New | +$488K |
|
4057
CVR Partners
UAN
$960M
| $488K | ﹤0.01% |
+7,446
| New | +$488K |
|
|
DSKE
4058
DELISTED
Daseke, Inc. Common Stock
DSKE
| $488K | ﹤0.01% |
+60,205
| New | +$488K |
|
4059
TScan Therapeutics
TCRX
$95.3M
| $488K | ﹤0.01% |
+83,622
| New | +$488K |
|
4060
Vanguard Small-Cap ETF
VB
$67.5B
| $487K | ﹤0.01% |
+2,285
| New | +$487K |
|
4061
Franklin FTSE Latin America
FLLA
$39.5M
| $487K | ﹤0.01% |
19,786
-70,252
| -78% | -$1.73M |
|
4062
CION Investment
CION
$510M
| $487K | ﹤0.01% |
43,086
+24,696
| +134% | +$279K |
|
4063
PIMCO Multi Sector Bond Active ETF
PYLD
$7.58B
| $487K | ﹤0.01% |
18,983
-18,700
| -50% | -$480K |
|
4064
Employers Holdings
EIG
$976M
| $487K | ﹤0.01% |
12,352
-5,853
| -32% | -$231K |
|
|
ALEX
4065
Alexander & Baldwin
ALEX
$1.33B
| $486K | ﹤0.01% |
25,557
+5,022
| +24% | +$95.5K |
|
4066
Zymeworks
ZYME
$1.21B
| $486K | ﹤0.01% |
+46,770
| New | +$486K |
|
4067
INmune Bio
INMB
$53.2M
| $486K | ﹤0.01% |
+43,134
| New | +$486K |
|
4068
TTM Technologies
TTMI
$5.14B
| $485K | ﹤0.01% |
30,670
-33,637
| -52% | -$532K |
|
4069
NGL Energy Partners
NGL
$821M
| $485K | ﹤0.01% |
86,989
-155,614
| -64% | -$867K |
|
4070
United Fire Group
UFCS
$795M
| $484K | ﹤0.01% |
+24,069
| New | +$484K |
|
|
GMRE
4071
Global Medical REIT
GMRE
$513M
| $484K | ﹤0.01% |
+43,622
| New | +$484K |
|
4072
Advantage Solutions
ADV
$606M
| $484K | ﹤0.01% |
+133,720
| New | +$484K |
|
4073
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.17B
| $484K | ﹤0.01% |
10,136
-43,085
| -81% | -$2.06M |
|
4074
ARS Pharmaceuticals
SPRY
$938M
| $483K | ﹤0.01% |
88,165
+66,713
| +311% | +$366K |
|
4075
Edgewise Therapeutics
EWTX
$1.47B
| $483K | ﹤0.01% |
+44,139
| New | +$483K |
|